The Massachusetts example isn’t the first time, of course, when it’s be crystal clear biotech folks are not fans of borders (as Wesley Smith noted the other day). There was a day not so long ago, in fact, when advocates of research on embryos were talking about a 14-day limit on the research lifespan of research embryos (I noted this in the N.J.-debate context a bit back, here). As one biotech lobbyist told the Kass commission: “I don’t know that it’s appropriate to say that limits on scientific research should stay static over the course of decades as things change.”